[ad_1] NEW DELHI: Two health advocacy groups have written to the Indian government asking it to terminate patents granted to Gilead Sciences for drug remdesivir so that it can be more fairly distributed to coronavirus patients worldwide, particularly in the poorer nations. Drug patents in India are an important issue …
Read More »